BIOVISION 2011 - PROGRAM
March 27-29
Cité Centre de Congrès, Lyon, France
Version: October 20 2010
In partnership with:
2
Table of contents
TABLE OF CONTENTS...... 3
BIOVISION PARTNERS ...... 6
PROGRAM FORMAT ...... 7
PRELIMINARY PROGRAM...... 9
Decision makers’ perspectives ...... 9 Plenary 1: Health, a right for all human beings, at any price? ...... 10 Plenary 2: Drugs and developing countries...... 11 Plenary 3: Synthetic biology: reconstructing life? ...... 12 Plenary 4: How will we be fed in 2020? ...... 13 Plenary 5: Would Pasteur and Fleming have survived the precautionary principle? ...... 14
Scientific Advances ...... 17
Health...... 17 Theme 1: Brain, emotions and social behavior...... 18 Theme 2: Can we “cure” aging? ...... 19 Theme 3: From systems biology to personalized medicine...... 20 Theme 4: Comprehending human brain function in the future ...... 21 Theme 5: Cancer research for personalized patient treatment ...... 22 Theme 6: How to deal with emerging and re-emerging infectious diseases? ...... 23 Theme 7: Cell therapy: scientific, therapeutic and ethical challenges...... 24
Environment ...... 25 Theme 8: Environment and CO2 ...... 26 Theme 9: Biofuels from Biomass...... 27 Theme 10: Turn Green into Gold...... 28
Nutrition...... 29 Theme 11: Health, nutrition and bacteria...... 30 Theme 12: More food and better food ...... 31
Business in science ...... 33 Workshop 1: How to address the volume challenge of chronic diseases in emerging countries...... 34 Workshop 2: How technology will help implementing innovative healthcare delivery? ...... 35 Workshop 3: How to solve R&D’s challenge with Open Innovation? ...... 36 Workshop 4: New Geography of R&D innovation in infectious and neglected diseases ...... 37
Social Events...... 39 Gala Dinner...... 39 Welcoming Night...... 39 Innovation Dinner...... 39 Networking Night...... 39 BioVision Award...... 39
3
Governance and Organisation
⇒ Steering Committee
The Steering Committee approves strategic orientations and gives formal expression to links with some of BioVision’s main partners.
Members:
• Patrick Aebischer, Chairman, EPFL – Ecole Polytechnique Fédérale de Lausanne (Switzerland) • Gérard Collomb, Senator and Mayor of Lyon, President of the Greater Lyon • Philippe Desmarescaux, Chairman and founder of BioVision • Amir Dossal, Executive Director of UNOP – UN Office for Partnerships (USA) • Eric Froment, Chairman, Fondation Scientifique de Lyon et du Sud-Est • Michel Lussault, Chairman of University of Lyon • Michel Mercier, Minister for Rural Areas and Regional Planning, and Chairman of the Rhone Department General Council • Alain Mérieux, Chairman, Institut Mérieux • Koji Omi, Founder and Chairman of the Science and Technology in Society (STS) forum (Japan) • Jacob Palis, Chairman, TWAS (The Academy of Sciences for the Developing World), (Brazil) • Jean-Jack Queyranne, former minister and Chairman of the Rhone-Alps Region • Ismail Serageldin, Director, Bibliotheca Alexandrina, Founder of BioVisionAlexandria (Egypt) • André Syrota, Chairman, National Life Sciences and Health Alliance • Elias Zerhouni, former director of NIH, Senior fellow, Bill and Melinda Gates Foundation (USA)
4
⇒ Scientific Committee
A new international scientific committee has been established in close partnership with the Academy of Sciences. The Committee is in charge of selecting the programme themes and suggesting speakers. The Committee is responsible for the programme scientific quality and is made up of internationally recognised personalities.
Chairman:
• Pr. François Gros, Permanent Honorary Secretary of the Academy of Sciences
Members:
• Pr. Pascale Cossart, Research Director, Institut Pasteur, Academy of Sciences • Pr. Evelyn Fox Keller, Professor, MIT (USA) • Pr. Richard Frackowiak, Professor, University of Lausanne (Switzerland) • Pr. Liselotte Højgaard, Professor, University of Copenhagen (Denmark) • Pr. Gnissa Konate, Director, Institut de l’environnement et des recherches agricoles (Burkina Faso) • Pr. Philippe Kourilsky, Professor, Collège de France • Pr. Jean-Marie Lehn, Professor, Collège de France, Nobel Laureate in Chemistry • Pr. Pierre-Marie Lledo, Director of Research, Institut Pasteur • Pr. Helga Nowotny, President, European Research Council (Austria) • Pr. Michael Oborne, Director of International Futures programme, OCDE (USA) • Pr. Thierry Philip, former Director of the Léon Bérard Centre • Pr. Jacques Samarut, President, ENS-Lyon • Pr. Philippe Sansonetti, Professor, Collège de France • Pr. François Taddei, Research Director, INSERM • Pr. Didier Trono, Dean of the Faculty of Life Sciences, EPFL (Switzerland)
5
BioVision Partners
6
Program Format
Official language: English
3 Tracks
Scientific Decision makers’ Business in Advances perspectives science
· 12 themes: · 6 themes · 3 themes -7 Health - Health -3 Environment - Environment -2 Nutrition - Nutrition
⇓⇓⇓ ⇓⇓⇓ ⇓⇓⇓
36 sessions 6 plenary sessions 3 round tables 12 round tables
⇓⇓⇓ ⇓⇓⇓ ⇓⇓⇓
100 speakers 30 speakers 20 speakers
150 speakers
2000 / 2500 participants
Preliminary Program
Decision makers’ perspectives
Please note that all the speakers mentioned in this document have been suggested by the Scientific Committee. Not all of them have been contacted yet.
Speakers indicated in bold have accepted our invitation.
Subjects and titles of sessions and talks are not final.
Plenary 1: Health, a right for all human beings, at any price?
Co-organized with Universcience
Sunday 27 March 2011 – 13:00 to 14:30
Moderator: Pr. Helga Nowotny (President, European Research Council – ERC)
Introduction: Pr. Claudie Haigneré (President, Universcience)
- Pr. Zhu Chen (Health Minister, China)
- Pr. Michael Marmot (Director, International Institute for Society and Health – University College London; Chairman, Commission on Social Determinants of Health – WHO, UK)
- Pr. Michel Kazatchkine (Executive Director, the Global Fund to Fight AIDS, Tuberculosis and Malaria)
- Pr. Esther Duflo (Clark Medal Laureate 2010, MIT, USA)
- Mr Chris Viehbacher (CEO, Sanofi-aventis)
10
Plenary 2: Drugs and developing countries
Sunday 27 March 2011 – 18:00 to 19:30
Moderator: Dr. Elias Zerhouni (Former Director NIH, Chair of Scientific Committee, Foundation Bill & Melinda Gates)
- Mr. Hatem el Gabaly (Health Minister, Egypt)
- Mr. José Angel Cordova Villalobos (Health Minister, Mexico)
- Pr. Awa Marie Coll Seck (Executive Director, Roll Back Malaria, Switzerland)
- Mr Alain Mérieux (Chairman, Mérieux Institute, France)
- Dr. Unni Karunakara (President, Médecins sans Frontières - MSF)
- Dr. Paul Stoffels (Global Head, R&D, Janssen, Pharmaceutical Companies of Johnson & Johnson)
11
Plenary 3: Synthetic biology: reconstructing life?
Co-organized with Vivagora
Monday 28 March 2011 – 12:00 to 13:15
Moderator - Introduction: Pr. Bernadette Bensaude-Vincent (President, Vivagora)
- Pr. Ada Yonath (Nobel Prize in Chemistry 2009, Israel)
- Pr Jean-Marie Lehn (Nobel Prize in Chemistry 1987, France)
- Pr. Edison Tak-Bun Liu (President, Human Genome Organisation - HUGO)
- Mrs. Nathalie Kosciusko-Morizet (Secretary of State for Forward Planning and Development of the Digital Economy, France) – Provisional agreement
- Pr. Michel Serres (Philosopher, France)
12
Plenary 4: How will we be fed in 2020?
Monday 28 March 2011 – 17:30 to 19:00
Moderator: Mrs Maria Cattaui (Member of the Board Petroplus Holding AG, Switzerland)
- Mr Antonio Tajani (European Commissioner, Industry and Entrepreneurship)
- Mr. Feike Sijbesma (CEO, DSM, The Netherlands)
- Mrs. Catherine Geslain-Lanéelle (Executive Director, European Food Safety Authority)
- Mr. François Danel (General Director, Action Contre la Faim)
- Mrs Josette Sheeran (Executive Director, World Food Programme) – Invited
13
Plenary 5: Would Pasteur and Fleming have survived the precautionary principle?
Tuesday 29 March 2011 – 12:00 to 13:15
Moderator: Pr. Ismail Serageldin (Director, Bibliotheca Alexandrina; Professor, College de France
Introduction: Pr. Philippe Kourilsky (Collège de France)
- Mrs Maire Geoghegan-Quinn (European Commissioner, Research, Innovation and Science) – provisional agreement
- Pr. Mark Walport (Chief Executive Director, Wellcome Trust, UK)
- Dr. Vishwa Mohan Katoch (Director, Indian Council of Medical Research, India)
- Mr. Anders Olauson (President, EuropeanPatients’ Forum)
- Dr. Thomas Lönngren (Executive Director, European Medicines Agency – EMA)
14
15
16
Scientific Advances
Health
17
Theme 1: Brain, emotions and social behavior
Sunday 27 March 2011 – 14:45 to 17:30
Chairperson: Pr. Pierre-Marie Lledo (Pasteur Institute, France)
Scientific sessions: Learning from Others
- Brain Science: a societal perspective. What is possible and what is desirable? Dr. Philip Campbell (Editor in Chief, Nature)
- Stress and Depression Pr. Carmen Sandi (EPFL, Lausanne, Switzerland)
- The social brain in adolescence Pr. Sarah Jayne Blakemore (Institute of Cognitive Neuroscience, University College London, London, UK) – Invited
Round table: When Biology meets Psychology and Social Sciences
Moderator:
- Dr. Snait B. Gissis (Cohn Institute, Tel Aviv University, Israel) Biological heredity and cultural inheritance
- Pr. Michael Tomasello (Max Planck Institute for Evolutionary Anthropology, Germany)
- Pr. Lisbeth Shepherd (Executive Director, Green City Force, Co-Founder Uniscité, New York, USA)
- Mrs. Rebecca Muller (Secretary General, Global Alliance of Mental Illness Advocacy Networks – GAMIAN)
- Mrs Lucy Vincent (General Director, External Affairs, Servier)
18
Theme 2: Can we “cure” aging?
Sunday 27 March 2011 – 15:00 to 17:30
Chairperson: Pr. Jean-Claude Ameisen (INSERM, France)
Scientific sessions: Title to be defined
- A retirement home for bacteria: study and understanding of aging Pr. François Taddei (INSERM, Hôpital Necker, France)
- System Biology and aging Pr. Thomas BL Kirkwood (Institute for Ageing and Health, Newcastle University, UK)
- Genetics of human aging Pr. Aviv Bergman (Albert Einstein College of Medicine, New York, USA) – Invited
Round table: Extending life: which consequences for all of us?
Moderator: Pr. Jean-Claude Ameisen
- Pr. James W. Vaupel (Max Planck Institute for Demographic Research, Germany)
- Pr. Miroslav Radman (INSERM, France)
- Dr John Beard (Director, Department of Ageing and Life Course, WHO, Switzerland) – Invited
- Mr. Paul Rübig (President, Science and Technology Options Assessment – STOA) – Invited
- Mr. Christophe Dardel (President, DSM Biomedical, The Netherlands)
19
Theme 3: From systems biology to personalized medicine
Monday 28 March 2011 – 09:00 to 11:45
Chairperson: Pr. Charles Auffray (European Institute for Systems Biology & Medicine)
Partners: Lyonbiopôle
Scientific sessions: Concepts, methods, strategies and ethics in systems biology and medicine
- Combining Eastern and Western approaches of biology into systems medicine Pr. Zhu Chen (Systems Biomedicine Center, Shanghai, China)
- Catalyzing the transition from reactive to proactive (P4) medicine through systems biology Pr. Lee Hood (Institute for Systems Biology, Seattle, USA)
- Bioinformatics and biobanking for systems biology and medicine Pr. Anthony J. Brookes (Department of Genetics, Leicester University, UK)
Round table: Defining a roadmap for systems medicine
Moderator:
- Pr. Sonia Abdelhak (Institut Pasteur, Tunis, Tunisia)
- Pr. Jean Bousquet (INSERM, and WHO Collaborating center, Montpellier, France)
- Pr. Anne Cambon-Thomsen (Genomics and Public Health, INSERM, Toulouse, France)
- Pr. Denis Noble (President IUPS - Department of Anatonomy, Genetics and Physiology, Oxford University, UK)
- Dr Jean-Jacques Garaud (Head of Research and Early Development, Roche)
20
Theme 4: Comprehending human brain function in the future
Monday 28 March 2011 – 14:30 to 17:15
Chairperson: Pr. Richard Frackowiak (University of Lausanne, Switzerland)
Partner: Neurodis
Scientific sessions: Harnessing modern computing to brain imaging: implications for psychology, neuroscience and neurology
- Visualizing the impact of education on the brain Pr. Stanislas Dehaene (INSERM-CEA, Collège de France, France)
- Predicting brain responses: The blue brain project Pr. Henry Markram (Director of the Center for Neuroscience & Technology, EPFL, Switzerland)
- Industrial scale image analysis – the future of neuroradiology Pr. John Mazziotta (UCLA Stroke center, LA, USA)
Round table: Understanding brain function: implication for society and the future
Moderator:
- Pr Jean-Pierre Changeux (French Academy of Sciences, College de France, France) – Invited
- Pr. Helen Mayberg (Emory University, Atlanta, USA)
- Pr. Wolf Singer (Max Planck Institute for Brain Research, Germany)
- Pr. Alim-Louis Benabid (Scientific Advisor, CEA-Grenoble, France)
- Dr Alan Gara (Blue Brain Project, IBM, USA) - Invited
21
Theme 5: Cancer research for personalized patient treatment
Tuesday 29 March 2011 – 09:00 to 11:45
Chairperson: Pr. Liselotte Højgaard (University of Copenhagen, Denmark)
Partner: Cancéropôle CLARA
Scientific sessions: Making the most of scientific achievements for a future being personalized, predictive and pre-emptive for cancer patients
- New technologies for diagnosis and treatment of cancer: imaging, robotics, etc. Pr. Roger Tsien (Nobel Prize in Chemistry 2008, University of California, USA)
- Targeted therapeutics, links with the genomic Pr. Jean-Yves Blay (President, European Organisation for Research and Treatment of Cancer, Leon Berard Center, France)
- For the elucidation of the molecular and cellular mechanisms at the origin of certain cancers in humans. Pr. Anne Dejean-Assémat (“For Women in Science” laureate, Pasteur Institute, INSERM, France)
Round table: Do we implement the scientific achievements into patient treatment and pharmaceutical innovation?
Moderator:
- Pr. Bertrand Coiffier (European Institute of Lymphoma, University of Lyon, France)
- Pr. Roger Tsien (Nobel Prize in Chemistry 2008, University of California, USA)
- Mr. Robert L T Hudson (President, European Cancer Patient Coalition – ECPC) – Invited
- Dr. Denis Lacombe (Scientific Director, European Organisation for Research and Treatment of Cancer – EORTC) – Invited
22
Theme 6: How to deal with emerging and re- emerging infectious diseases?
Tuesday 29 March 2011 – 09:00 to 11:45
Chairperson: Pr. Pascale Cossart (Pasteur Institute, France)
Partners: Lyonbiopôle
Scientific sessions: Towards new strategies to fight emerging or re-emerging diseases
- Flu, a striking example of emerging disease Pr. Yoshihiro Kawaoka (University of Wisconsin, USA)
- Predisposition, genetic resistance to some infectious diseases Pr. Laurent Abel (INSERM 550, Necker Hospital, France)
- New method to develop antibiotics Pr. Peter Leadlay (Cambridge University, UK)
Round table: Have we considered all parameters?
Moderator:
- Pr. Peter Piot (Former Executive Director UNAIDS: 1994-2008, UK)
- Pr. Françoise Barre-Sinoussi (Nobel Prize in Medicine 2008, INSERM, France)
- Mrs Tran Thi Trung Chien (Former Health Minister, Vietnam)
- Pr. Bruno Lina (Head, National Reference Centre for Influenza; Head, Diagnostic Virology Laboratories, University of Lyon)
- Dr Peter Mueller (Executive Vice President, Global Research and Development, and Chief Scientific Officer, Vertex Pharmaceuticals, USA)
- Pr. Jeffrey Almond (Head of Discovery Research and Extrernal R&D, Sanofi Pasteur, France)
23
Theme 7: Cell therapy: scientific, therapeutic and ethical challenges
Tuesday 29 March 2011 – 09:00 to 11:45
Chairperson: Pr. Didier Trono (EPFL, Lausanne, Switzerland)
Partner: Neurodis
Scientific sessions: Success and promises
- The new gene therapy: a new hope Pr. Luigi Naldini (San Raffaele del Monte Tabor Foundation, Milano, Italia)
- Stem cells: where are the bottlenecks? Pr Martin Evans (Nobel Prize in Medicine 2007, Cardiff University, UK) – Invited
- Stem cell research and regenerative medicine: a new therapy for chronic disease Pr. Alan Trounson (California Institute for Regenerative Medicine, San Francisco, USA)
Round table: Societal and Ethical key issues: the citizen’s rights
Moderator:
- Pr. Alain Fischer (INSERM, France)
- Pr. Anne Cambon-Thomsen (Genomics and Public Health, INSERM, Toulouse, France)
- Pr. Eva Pebay-Peyroula (President, Agence Nationale pour la Recherche; Director, Institute of Biologie Structurale, Grenoble, France) – Invited
- Mgr. Jacques Suaudeau (Scientific Director, Pontifical Academy for Life, Vatican) – Invited
- Mr. Paul Rübig (President, Science and Technology Options Assessment – STOA)
- Mr. Christian Béchon (CEO, LFB)
24
Scientific Advances
Environment
25
Theme 8: Environment and CO2
Sunday 27 March 2011 – 14:45 to 17:30
Chairperson: Pr. Chris Bowler (ENS Paris, France)
Scientific sessions: Impacts of oceans, forests and agriculture on the carbon cycle
- Carbon capture by forests Pr Simon Lewis (University of Leeds, UK)
- Ocean acidification and consequences on the selection of diatoms algae Dr. Debora Iglesias-Rodriguez (School of Ocean and Earth Science University of Southampton, UK)
- Reduction of nitrogen used in agriculture Pr Giles Oldroyd (John Innes Center, Norwich, UK)
Round table: mitigating CO2: bio or non-bio solutions?
Moderator: Pr. Chris Bowler
- Pr. Victor Smetacek (Institute Alfred Wegener, Germany)
- Dr Jason Clay (Senior Vice President of Market Transformation, WWF)
- Dr. Ben Halpern (Project Coordinator, National Center for Ecological Analysis and Synthesis, Santa Barbara, USA) – Invited
26
Theme 9: Biofuels from Biomass
Monday 28 March 2011 – 9:00 to 11:45
Chairperson: Pr. Bernard Bigot (CEA, France)
Scientific sessions: New sources of Biofuel
- Algae, fuel or feed Pr. Jonathan Gressel (TransAlgae Ltd, Israel)
- Biomass conversion to biofuels and Lignocellulose enzymology Pr. Liisa Viikari (University of Helsinki, Finland)
- Plant biomass utilisation Pr Keith Waldron (Institute of Food Research, Norwich, UK)
Round table: What are the realistic options?
Moderator: Pr. Bernard Bigot
- Mrs Martina Otto (Head of policy unit, United Nations Environment Programme - UNEP)
- Pr. Marion Guillou (CEO, INRA, France) – Provisional agreement
- Mr. Marcos Sawaya Jank (President, Brazilian Sugarcane Industry Association – UNICA) – Invited
- Mr. Frederic Hauge (President, Bellona Foundation, Norway)
- Dr Vincent Schachter (Vice-President, R&D, Total Gas and Power)
27
Theme 10: Turn Green into Gold
Monday 28 March 2011 – 14:30 to 17:15
Chairperson: Dr Jason Clay (Senior Vice President of Market Transformation, WWF)
Scientific sessions: Biorefineries
- State of the art for biorefineries Pr. Manfred Kircher (President, Board of Industrial Biotechnology Cluster CLIB2021, Germany)
- Thermochemical processing of biomass
- White biotechnologies Pr. Michael O’Donohue (INRA, Division CEPIA, Toulouse, France)
Round table: The role of Biorefinery in the Biobased Economy
Moderator: Dr Jason Clay
- Mrs Maire Geoghegan-Quinn (European Commissioner, Research, Innovation and Science) - provisional agreement
- M. Rob van Leen (CIO, Royal DSM, The Netherlands)
- Dr. Susan A. Mainka (Head, Science and Learning, IUCN, Switzerland)
- Mr. Olivier Appert (President, Institut Français du pétrole; President, Alliance Nationale de Coordination de la Recherche pour l'Énergie – ANCRE) – Invited
28
Scientific Advances
Nutrition
29
Theme 11: Health, nutrition and bacteria
Monday 28 March 2011 – 9:00 to 11:45
Chairperson: Pr. Sven Pettersson (Karolinska Institute, Sweden)
Scientific sessions: Title to be defined
- Pro and prebiotics Pr. Arjan Narbad (Institute of Food research, Norwich, UK)
- Interface between nutrition and signalling Pr. Walter Wahli (Centre intégratif de génomique, University of Lausanne, Switzerland)
- Microflora and resistance to insulin Pr. Remy Burcelin (INSERM, Toulouse, France)
Round table: Neutraceuticals: luxury niche or new hope for global nutrition?
Moderator: Pr. Sven Petterson
- Mrs. Catherine Geslain-Lanéelle (Executive Director, European Food Safety Authority)
- Mr. José Angel Cordova Villalobos (Health Minister, Mexico)
- Dr. Fernando GABILONDO (Director, Institute National de la Nutrition Mexico)
- Pr. Pascale Briand (General Director for Food, French Agriculture Ministry) – Provisional Agreement
- Pr. Martine Laville (Director, Centre de Recherche en Nutrition Humaine – CRNH, Lyon, France)
30
Theme 12: More food and better food
Monday 28 March 2011 – 14:30 to 17:15
Chairperson: Dr. Matthew Hills (Norwich Research Park)
Partner: Norwich Research Park
Scientific sessions: For more food – better food
- Outline the challenges facing the world in increasing crop yields and biomass Pr. Donald Ort (University of Urbana-Champaign, Illinois, USA)
- New plants – lower inputs Pr. Anne Osbourn (John Innes Center, Norwich, UK)
- Nutritional quality of food and effects on health Pr. Cathie Martin (John Innes Center, Norwich, UK)
Round table: Which new agronomy for a sustainable and productive agriculture?
Moderator: Pr. Donald Ort
- Pr. Marion Guillou (CEO, INRA, France)
- Dr. Claudia Paoletti (Senior Scientific Officer, GMO Unit, European Food Safety Authority)
- Mr. François Danel (General Director, Action Contre la Faim)
- Mr. Jay Naidoo (Chairman, Global Alliance for Improved Nutrition – GAIN) – Invited
31
32
Business in science
The end of the traditional life science industry model: What’s next?
Co-organized with Lyonbiopôle, France Biotech, McKinsey and Co
Workshop 1: How to address the volume challenge of chronic diseases in emerging countries
Moderator:
Introduction: TBD
- Mr Antonio Tajani (European Commissioner, Industry and Entrepreneurship)
- Mr. Hatem el Gabaly (Health minister, Egypt)
- Dr Zeng Bing (VP, China National Pharmaceutical Group Corp, SINOPHARM) – Invited
- Dr. Vishwa Mohan Katoch (Director, Indian Council of Medical Research)
- Mr Olivier Charmeil (Senior VP Asia/Pacific & Japan, Sanofi-aventis)
34
Workshop 2: How technology will help implementing innovative healthcare delivery?
Moderator: Dr Olivier Raynaud (Sr Director, Health Initiatives, World Economic Forum) - Provisional agreement
Introduction: TBD
- Ms. Maire Geoghegan-Quinn (European Commissioner, Research, Innovation and Science) – Provisional agreement
- Ms. Nathalie Kosciusko-Morizet (Secretary of State for Forward Planning and Development of the Digital Economy) – Provisional agreement
- M Neil de Crescenzo (Sr VP and General Manager, Oracle Health Sciences)
- Speaker from Cisco or Intel
35
Workshop 3: How to solve R&D’s challenge with Open Innovation?
Moderator: Dr André Choulika (President, France Biotech, France)
Introduction: TBD
- Pr. Lee Hood (President, Institute for Systems Biology, USA; Co-founder Amgen, Applied Biosystems, Rosetta, USA)
- Pr. Michel Goldman (Executive Director, Innovative Medicine Initiative)
- Dr Philippe Archinard (CEO, Transgene)
- Dr Vincent Schachter (VP, R&D, Total Gas and Power)
- M. Jacques Delort (VP, Prospective Strategic Initiatives, Sanofi-aventis)
36
Workshop 4: New Geography of R&D innovation in infectious and neglected diseases
Moderator: TBD
Introduction: Prof. Awa-Marie Coll Seck , Executive Director, Roll Back Malaria
- Dr Johan Van Hoof, (Global Therapeutic Area Head for Infectious Diseases & Vaccines, Head of the Global Development Organization, Pharmaceuticals Group, Johnson & Johnson)
- Dr. Robert Sebbag (VP, Access to Medicines, Sanofi-aventis)
- Dr. Thomas Lönngren (Executive Director, EMA)
- Pr. Françoise Barré-Sinoussi (Nobel Prize in Medicine 2008, Professor, Head of Unit of regulation of retroviral infections, Institut Pasteur, Paris, France)
- Dr. John A. Thomson (VP, Strategic R&D Networks, Vertex Pharmaceuticals)
- Speaker from Genzyme
37
38
Social Events
Gala Dinner (150 VIP) Sunday 27 March 2011
Seizing Nature’s opportunities would be good Mrs Julia Marton-Lefèvre (Director General, IUCN, Switzerland)
Welcoming Night (all participants) Sunday 27 March 2011
Innovation Dinner (150 VIP) Monday 28 March 2011
Biology inspires leaders and creators (to be confirmed)
Networking Night (all participants) Monday 28 March 2011
BioVision Award Tuesday 29 March 2011
39
CONTACT INFORMATION :
Fondation Scientifique de Lyon – BioVision - 210 avenue Jean Jaurès 69007 Lyon T : +33 (0)4 78 92 70 00 – F : +33 (0)4 78 92 70 15 - E-mail : [email protected]
www.biovision.org www.fslse.org
Avec le soutien de :
40
BIOVISION 2011 - PROGRAM
March 27-29
Cité Centre de Congrès, Lyon, France
Version: October 20 2010
In partnership with:
2
Table of contents
TABLE OF CONTENTS...... 3
BIOVISION PARTNERS ...... 6
PROGRAM FORMAT ...... 7
PRELIMINARY PROGRAM...... 9
Decision makers’ perspectives ...... 9 Plenary 1: Health, a right for all human beings, at any price? ...... 10 Plenary 2: Drugs and developing countries...... 11 Plenary 3: Synthetic biology: reconstructing life? ...... 12 Plenary 4: How will we be fed in 2020? ...... 13 Plenary 5: Would Pasteur and Fleming have survived the precautionary principle? ...... 14
Scientific Advances ...... 17
Health...... 17 Theme 1: Brain, emotions and social behavior...... 18 Theme 2: Can we “cure” aging? ...... 19 Theme 3: From systems biology to personalized medicine...... 20 Theme 4: Comprehending human brain function in the future ...... 21 Theme 5: Cancer research for personalized patient treatment ...... 22 Theme 6: How to deal with emerging and re-emerging infectious diseases? ...... 23 Theme 7: Cell therapy: scientific, therapeutic and ethical challenges...... 24
Environment ...... 25 Theme 8: Environment and CO2 ...... 26 Theme 9: Biofuels from Biomass...... 27 Theme 10: Turn Green into Gold...... 28
Nutrition...... 29 Theme 11: Health, nutrition and bacteria...... 30 Theme 12: More food and better food ...... 31
Business in science ...... 33 Workshop 1: How to address the volume challenge of chronic diseases in emerging countries...... 34 Workshop 2: How technology will help implementing innovative healthcare delivery? ...... 35 Workshop 3: How to solve R&D’s challenge with Open Innovation? ...... 36 Workshop 4: New Geography of R&D innovation in infectious and neglected diseases ...... 37
Social Events...... 39 Gala Dinner...... 39 Welcoming Night...... 39 Innovation Dinner...... 39 Networking Night...... 39 BioVision Award...... 39
3
Governance and Organisation
⇒ Steering Committee
The Steering Committee approves strategic orientations and gives formal expression to links with some of BioVision’s main partners.
Members:
• Patrick Aebischer, Chairman, EPFL – Ecole Polytechnique Fédérale de Lausanne (Switzerland) • Gérard Collomb, Senator and Mayor of Lyon, President of the Greater Lyon • Philippe Desmarescaux, Chairman and founder of BioVision • Amir Dossal, Executive Director of UNOP – UN Office for Partnerships (USA) • Eric Froment, Chairman, Fondation Scientifique de Lyon et du Sud-Est • Michel Lussault, Chairman of University of Lyon • Michel Mercier, Minister for Rural Areas and Regional Planning, and Chairman of the Rhone Department General Council • Alain Mérieux, Chairman, Institut Mérieux • Koji Omi, Founder and Chairman of the Science and Technology in Society (STS) forum (Japan) • Jacob Palis, Chairman, TWAS (The Academy of Sciences for the Developing World), (Brazil) • Jean-Jack Queyranne, former minister and Chairman of the Rhone-Alps Region • Ismail Serageldin, Director, Bibliotheca Alexandrina, Founder of BioVisionAlexandria (Egypt) • André Syrota, Chairman, National Life Sciences and Health Alliance • Elias Zerhouni, former director of NIH, Senior fellow, Bill and Melinda Gates Foundation (USA)
4
⇒ Scientific Committee
A new international scientific committee has been established in close partnership with the Academy of Sciences. The Committee is in charge of selecting the programme themes and suggesting speakers. The Committee is responsible for the programme scientific quality and is made up of internationally recognised personalities.
Chairman:
• Pr. François Gros, Permanent Honorary Secretary of the Academy of Sciences
Members:
• Pr. Pascale Cossart, Research Director, Institut Pasteur, Academy of Sciences • Pr. Evelyn Fox Keller, Professor, MIT (USA) • Pr. Richard Frackowiak, Professor, University of Lausanne (Switzerland) • Pr. Liselotte Højgaard, Professor, University of Copenhagen (Denmark) • Pr. Gnissa Konate, Director, Institut de l’environnement et des recherches agricoles (Burkina Faso) • Pr. Philippe Kourilsky, Professor, Collège de France • Pr. Jean-Marie Lehn, Professor, Collège de France, Nobel Laureate in Chemistry • Pr. Pierre-Marie Lledo, Director of Research, Institut Pasteur • Pr. Helga Nowotny, President, European Research Council (Austria) • Pr. Michael Oborne, Director of International Futures programme, OCDE (USA) • Pr. Thierry Philip, former Director of the Léon Bérard Centre • Pr. Jacques Samarut, President, ENS-Lyon • Pr. Philippe Sansonetti, Professor, Collège de France • Pr. François Taddei, Research Director, INSERM • Pr. Didier Trono, Dean of the Faculty of Life Sciences, EPFL (Switzerland)
5
BioVision Partners
6
Program Format
Official language: English
3 Tracks
Scientific Decision makers’ Business in Advances perspectives science
· 12 themes: · 6 themes · 3 themes -7 Health - Health -3 Environment - Environment -2 Nutrition - Nutrition
⇓⇓⇓ ⇓⇓⇓ ⇓⇓⇓
36 sessions 6 plenary sessions 3 round tables 12 round tables
⇓⇓⇓ ⇓⇓⇓ ⇓⇓⇓
100 speakers 30 speakers 20 speakers
150 speakers
2000 / 2500 participants
Preliminary Program
Decision makers’ perspectives
Please note that all the speakers mentioned in this document have been suggested by the Scientific Committee. Not all of them have been contacted yet.
Speakers indicated in bold have accepted our invitation.
Subjects and titles of sessions and talks are not final.
Plenary 1: Health, a right for all human beings, at any price?
Co-organized with Universcience
Sunday 27 March 2011 – 13:00 to 14:30
Moderator: Pr. Helga Nowotny (President, European Research Council – ERC)
Introduction: Pr. Claudie Haigneré (President, Universcience)
- Pr. Zhu Chen (Health Minister, China)
- Pr. Michael Marmot (Director, International Institute for Society and Health – University College London; Chairman, Commission on Social Determinants of Health – WHO, UK)
- Pr. Michel Kazatchkine (Executive Director, the Global Fund to Fight AIDS, Tuberculosis and Malaria)
- Pr. Esther Duflo (Clark Medal Laureate 2010, MIT, USA)
- Mr Chris Viehbacher (CEO, Sanofi-aventis)
10
Plenary 2: Drugs and developing countries
Sunday 27 March 2011 – 18:00 to 19:30
Moderator: Dr. Elias Zerhouni (Former Director NIH, Chair of Scientific Committee, Foundation Bill & Melinda Gates)
- Mr. Hatem el Gabaly (Health Minister, Egypt)
- Mr. José Angel Cordova Villalobos (Health Minister, Mexico)
- Pr. Awa Marie Coll Seck (Executive Director, Roll Back Malaria, Switzerland)
- Mr Alain Mérieux (Chairman, Mérieux Institute, France)
- Dr. Unni Karunakara (President, Médecins sans Frontières - MSF)
- Dr. Paul Stoffels (Global Head, R&D, Janssen, Pharmaceutical Companies of Johnson & Johnson)
11
Plenary 3: Synthetic biology: reconstructing life?
Co-organized with Vivagora
Monday 28 March 2011 – 12:00 to 13:15
Moderator - Introduction: Pr. Bernadette Bensaude-Vincent (President, Vivagora)
- Pr. Ada Yonath (Nobel Prize in Chemistry 2009, Israel)
- Pr Jean-Marie Lehn (Nobel Prize in Chemistry 1987, France)
- Pr. Edison Tak-Bun Liu (President, Human Genome Organisation - HUGO)
- Mrs. Nathalie Kosciusko-Morizet (Secretary of State for Forward Planning and Development of the Digital Economy, France) – Provisional agreement
- Pr. Michel Serres (Philosopher, France)
12
Plenary 4: How will we be fed in 2020?
Monday 28 March 2011 – 17:30 to 19:00
Moderator: Mrs Maria Cattaui (Member of the Board Petroplus Holding AG, Switzerland)
- Mr Antonio Tajani (European Commissioner, Industry and Entrepreneurship)
- Mr. Feike Sijbesma (CEO, DSM, The Netherlands)
- Mrs. Catherine Geslain-Lanéelle (Executive Director, European Food Safety Authority)
- Mr. François Danel (General Director, Action Contre la Faim)
- Mrs Josette Sheeran (Executive Director, World Food Programme) – Invited
13
Plenary 5: Would Pasteur and Fleming have survived the precautionary principle?
Tuesday 29 March 2011 – 12:00 to 13:15
Moderator: Pr. Ismail Serageldin (Director, Bibliotheca Alexandrina; Professor, College de France
Introduction: Pr. Philippe Kourilsky (Collège de France)
- Mrs Maire Geoghegan-Quinn (European Commissioner, Research, Innovation and Science) – provisional agreement
- Pr. Mark Walport (Chief Executive Director, Wellcome Trust, UK)
- Dr. Vishwa Mohan Katoch (Director, Indian Council of Medical Research, India)
- Mr. Anders Olauson (President, EuropeanPatients’ Forum)
- Dr. Thomas Lönngren (Executive Director, European Medicines Agency – EMA)
14
15
16
Scientific Advances
Health
17
Theme 1: Brain, emotions and social behavior
Sunday 27 March 2011 – 14:45 to 17:30
Chairperson: Pr. Pierre-Marie Lledo (Pasteur Institute, France)
Scientific sessions: Learning from Others
- Brain Science: a societal perspective. What is possible and what is desirable? Dr. Philip Campbell (Editor in Chief, Nature)
- Stress and Depression Pr. Carmen Sandi (EPFL, Lausanne, Switzerland)
- The social brain in adolescence Pr. Sarah Jayne Blakemore (Institute of Cognitive Neuroscience, University College London, London, UK) – Invited
Round table: When Biology meets Psychology and Social Sciences
Moderator:
- Dr. Snait B. Gissis (Cohn Institute, Tel Aviv University, Israel) Biological heredity and cultural inheritance
- Pr. Michael Tomasello (Max Planck Institute for Evolutionary Anthropology, Germany)
- Pr. Lisbeth Shepherd (Executive Director, Green City Force, Co-Founder Uniscité, New York, USA)
- Mrs. Rebecca Muller (Secretary General, Global Alliance of Mental Illness Advocacy Networks – GAMIAN)
- Mrs Lucy Vincent (General Director, External Affairs, Servier)
18
Theme 2: Can we “cure” aging?
Sunday 27 March 2011 – 15:00 to 17:30
Chairperson: Pr. Jean-Claude Ameisen (INSERM, France)
Scientific sessions: Title to be defined
- A retirement home for bacteria: study and understanding of aging Pr. François Taddei (INSERM, Hôpital Necker, France)
- System Biology and aging Pr. Thomas BL Kirkwood (Institute for Ageing and Health, Newcastle University, UK)
- Genetics of human aging Pr. Aviv Bergman (Albert Einstein College of Medicine, New York, USA) – Invited
Round table: Extending life: which consequences for all of us?
Moderator: Pr. Jean-Claude Ameisen
- Pr. James W. Vaupel (Max Planck Institute for Demographic Research, Germany)
- Pr. Miroslav Radman (INSERM, France)
- Dr John Beard (Director, Department of Ageing and Life Course, WHO, Switzerland) – Invited
- Mr. Paul Rübig (President, Science and Technology Options Assessment – STOA) – Invited
- Mr. Christophe Dardel (President, DSM Biomedical, The Netherlands)
19
Theme 3: From systems biology to personalized medicine
Monday 28 March 2011 – 09:00 to 11:45
Chairperson: Pr. Charles Auffray (European Institute for Systems Biology & Medicine)
Partners: Lyonbiopôle
Scientific sessions: Concepts, methods, strategies and ethics in systems biology and medicine
- Combining Eastern and Western approaches of biology into systems medicine Pr. Zhu Chen (Systems Biomedicine Center, Shanghai, China)
- Catalyzing the transition from reactive to proactive (P4) medicine through systems biology Pr. Lee Hood (Institute for Systems Biology, Seattle, USA)
- Bioinformatics and biobanking for systems biology and medicine Pr. Anthony J. Brookes (Department of Genetics, Leicester University, UK)
Round table: Defining a roadmap for systems medicine
Moderator:
- Pr. Sonia Abdelhak (Institut Pasteur, Tunis, Tunisia)
- Pr. Jean Bousquet (INSERM, and WHO Collaborating center, Montpellier, France)
- Pr. Anne Cambon-Thomsen (Genomics and Public Health, INSERM, Toulouse, France)
- Pr. Denis Noble (President IUPS - Department of Anatonomy, Genetics and Physiology, Oxford University, UK)
- Dr Jean-Jacques Garaud (Head of Research and Early Development, Roche)
20
Theme 4: Comprehending human brain function in the future
Monday 28 March 2011 – 14:30 to 17:15
Chairperson: Pr. Richard Frackowiak (University of Lausanne, Switzerland)
Partner: Neurodis
Scientific sessions: Harnessing modern computing to brain imaging: implications for psychology, neuroscience and neurology
- Visualizing the impact of education on the brain Pr. Stanislas Dehaene (INSERM-CEA, Collège de France, France)
- Predicting brain responses: The blue brain project Pr. Henry Markram (Director of the Center for Neuroscience & Technology, EPFL, Switzerland)
- Industrial scale image analysis – the future of neuroradiology Pr. John Mazziotta (UCLA Stroke center, LA, USA)
Round table: Understanding brain function: implication for society and the future
Moderator:
- Pr Jean-Pierre Changeux (French Academy of Sciences, College de France, France) – Invited
- Pr. Helen Mayberg (Emory University, Atlanta, USA)
- Pr. Wolf Singer (Max Planck Institute for Brain Research, Germany)
- Pr. Alim-Louis Benabid (Scientific Advisor, CEA-Grenoble, France)
- Dr Alan Gara (Blue Brain Project, IBM, USA) - Invited
21
Theme 5: Cancer research for personalized patient treatment
Tuesday 29 March 2011 – 09:00 to 11:45
Chairperson: Pr. Liselotte Højgaard (University of Copenhagen, Denmark)
Partner: Cancéropôle CLARA
Scientific sessions: Making the most of scientific achievements for a future being personalized, predictive and pre-emptive for cancer patients
- New technologies for diagnosis and treatment of cancer: imaging, robotics, etc. Pr. Roger Tsien (Nobel Prize in Chemistry 2008, University of California, USA)
- Targeted therapeutics, links with the genomic Pr. Jean-Yves Blay (President, European Organisation for Research and Treatment of Cancer, Leon Berard Center, France)
- For the elucidation of the molecular and cellular mechanisms at the origin of certain cancers in humans. Pr. Anne Dejean-Assémat (“For Women in Science” laureate, Pasteur Institute, INSERM, France)
Round table: Do we implement the scientific achievements into patient treatment and pharmaceutical innovation?
Moderator:
- Pr. Bertrand Coiffier (European Institute of Lymphoma, University of Lyon, France)
- Pr. Roger Tsien (Nobel Prize in Chemistry 2008, University of California, USA)
- Mr. Robert L T Hudson (President, European Cancer Patient Coalition – ECPC) – Invited
- Dr. Denis Lacombe (Scientific Director, European Organisation for Research and Treatment of Cancer – EORTC) – Invited
22
Theme 6: How to deal with emerging and re- emerging infectious diseases?
Tuesday 29 March 2011 – 09:00 to 11:45
Chairperson: Pr. Pascale Cossart (Pasteur Institute, France)
Partners: Lyonbiopôle
Scientific sessions: Towards new strategies to fight emerging or re-emerging diseases
- Flu, a striking example of emerging disease Pr. Yoshihiro Kawaoka (University of Wisconsin, USA)
- Predisposition, genetic resistance to some infectious diseases Pr. Laurent Abel (INSERM 550, Necker Hospital, France)
- New method to develop antibiotics Pr. Peter Leadlay (Cambridge University, UK)
Round table: Have we considered all parameters?
Moderator:
- Pr. Peter Piot (Former Executive Director UNAIDS: 1994-2008, UK)
- Pr. Françoise Barre-Sinoussi (Nobel Prize in Medicine 2008, INSERM, France)
- Mrs Tran Thi Trung Chien (Former Health Minister, Vietnam)
- Pr. Bruno Lina (Head, National Reference Centre for Influenza; Head, Diagnostic Virology Laboratories, University of Lyon)
- Dr Peter Mueller (Executive Vice President, Global Research and Development, and Chief Scientific Officer, Vertex Pharmaceuticals, USA)
- Pr. Jeffrey Almond (Head of Discovery Research and Extrernal R&D, Sanofi Pasteur, France)
23
Theme 7: Cell therapy: scientific, therapeutic and ethical challenges
Tuesday 29 March 2011 – 09:00 to 11:45
Chairperson: Pr. Didier Trono (EPFL, Lausanne, Switzerland)
Partner: Neurodis
Scientific sessions: Success and promises
- The new gene therapy: a new hope Pr. Luigi Naldini (San Raffaele del Monte Tabor Foundation, Milano, Italia)
- Stem cells: where are the bottlenecks? Pr Martin Evans (Nobel Prize in Medicine 2007, Cardiff University, UK) – Invited
- Stem cell research and regenerative medicine: a new therapy for chronic disease Pr. Alan Trounson (California Institute for Regenerative Medicine, San Francisco, USA)
Round table: Societal and Ethical key issues: the citizen’s rights
Moderator:
- Pr. Alain Fischer (INSERM, France)
- Pr. Anne Cambon-Thomsen (Genomics and Public Health, INSERM, Toulouse, France)
- Pr. Eva Pebay-Peyroula (President, Agence Nationale pour la Recherche; Director, Institute of Biologie Structurale, Grenoble, France) – Invited
- Mgr. Jacques Suaudeau (Scientific Director, Pontifical Academy for Life, Vatican) – Invited
- Mr. Paul Rübig (President, Science and Technology Options Assessment – STOA)
- Mr. Christian Béchon (CEO, LFB)
24
Scientific Advances
Environment
25
Theme 8: Environment and CO2
Sunday 27 March 2011 – 14:45 to 17:30
Chairperson: Pr. Chris Bowler (ENS Paris, France)
Scientific sessions: Impacts of oceans, forests and agriculture on the carbon cycle
- Carbon capture by forests Pr Simon Lewis (University of Leeds, UK)
- Ocean acidification and consequences on the selection of diatoms algae Dr. Debora Iglesias-Rodriguez (School of Ocean and Earth Science University of Southampton, UK)
- Reduction of nitrogen used in agriculture Pr Giles Oldroyd (John Innes Center, Norwich, UK)
Round table: mitigating CO2: bio or non-bio solutions?
Moderator: Pr. Chris Bowler
- Pr. Victor Smetacek (Institute Alfred Wegener, Germany)
- Dr Jason Clay (Senior Vice President of Market Transformation, WWF)
- Dr. Ben Halpern (Project Coordinator, National Center for Ecological Analysis and Synthesis, Santa Barbara, USA) – Invited
26
Theme 9: Biofuels from Biomass
Monday 28 March 2011 – 9:00 to 11:45
Chairperson: Pr. Bernard Bigot (CEA, France)
Scientific sessions: New sources of Biofuel
- Algae, fuel or feed Pr. Jonathan Gressel (TransAlgae Ltd, Israel)
- Biomass conversion to biofuels and Lignocellulose enzymology Pr. Liisa Viikari (University of Helsinki, Finland)
- Plant biomass utilisation Pr Keith Waldron (Institute of Food Research, Norwich, UK)
Round table: What are the realistic options?
Moderator: Pr. Bernard Bigot
- Mrs Martina Otto (Head of policy unit, United Nations Environment Programme - UNEP)
- Pr. Marion Guillou (CEO, INRA, France) – Provisional agreement
- Mr. Marcos Sawaya Jank (President, Brazilian Sugarcane Industry Association – UNICA) – Invited
- Mr. Frederic Hauge (President, Bellona Foundation, Norway)
- Dr Vincent Schachter (Vice-President, R&D, Total Gas and Power)
27
Theme 10: Turn Green into Gold
Monday 28 March 2011 – 14:30 to 17:15
Chairperson: Dr Jason Clay (Senior Vice President of Market Transformation, WWF)
Scientific sessions: Biorefineries
- State of the art for biorefineries Pr. Manfred Kircher (President, Board of Industrial Biotechnology Cluster CLIB2021, Germany)
- Thermochemical processing of biomass
- White biotechnologies Pr. Michael O’Donohue (INRA, Division CEPIA, Toulouse, France)
Round table: The role of Biorefinery in the Biobased Economy
Moderator: Dr Jason Clay
- Mrs Maire Geoghegan-Quinn (European Commissioner, Research, Innovation and Science) - provisional agreement
- M. Rob van Leen (CIO, Royal DSM, The Netherlands)
- Dr. Susan A. Mainka (Head, Science and Learning, IUCN, Switzerland)
- Mr. Olivier Appert (President, Institut Français du pétrole; President, Alliance Nationale de Coordination de la Recherche pour l'Énergie – ANCRE) – Invited
28
Scientific Advances
Nutrition
29
Theme 11: Health, nutrition and bacteria
Monday 28 March 2011 – 9:00 to 11:45
Chairperson: Pr. Sven Pettersson (Karolinska Institute, Sweden)
Scientific sessions: Title to be defined
- Pro and prebiotics Pr. Arjan Narbad (Institute of Food research, Norwich, UK)
- Interface between nutrition and signalling Pr. Walter Wahli (Centre intégratif de génomique, University of Lausanne, Switzerland)
- Microflora and resistance to insulin Pr. Remy Burcelin (INSERM, Toulouse, France)
Round table: Neutraceuticals: luxury niche or new hope for global nutrition?
Moderator: Pr. Sven Petterson
- Mrs. Catherine Geslain-Lanéelle (Executive Director, European Food Safety Authority)
- Mr. José Angel Cordova Villalobos (Health Minister, Mexico)
- Dr. Fernando GABILONDO (Director, Institute National de la Nutrition Mexico)
- Pr. Pascale Briand (General Director for Food, French Agriculture Ministry) – Provisional Agreement
- Pr. Martine Laville (Director, Centre de Recherche en Nutrition Humaine – CRNH, Lyon, France)
30
Theme 12: More food and better food
Monday 28 March 2011 – 14:30 to 17:15
Chairperson: Dr. Matthew Hills (Norwich Research Park)
Partner: Norwich Research Park
Scientific sessions: For more food – better food
- Outline the challenges facing the world in increasing crop yields and biomass Pr. Donald Ort (University of Urbana-Champaign, Illinois, USA)
- New plants – lower inputs Pr. Anne Osbourn (John Innes Center, Norwich, UK)
- Nutritional quality of food and effects on health Pr. Cathie Martin (John Innes Center, Norwich, UK)
Round table: Which new agronomy for a sustainable and productive agriculture?
Moderator: Pr. Donald Ort
- Pr. Marion Guillou (CEO, INRA, France)
- Dr. Claudia Paoletti (Senior Scientific Officer, GMO Unit, European Food Safety Authority)
- Mr. François Danel (General Director, Action Contre la Faim)
- Mr. Jay Naidoo (Chairman, Global Alliance for Improved Nutrition – GAIN) – Invited
31
32
Business in science
The end of the traditional life science industry model: What’s next?
Co-organized with Lyonbiopôle, France Biotech, McKinsey and Co
Workshop 1: How to address the volume challenge of chronic diseases in emerging countries
Moderator:
Introduction: TBD
- Mr Antonio Tajani (European Commissioner, Industry and Entrepreneurship)
- Mr. Hatem el Gabaly (Health minister, Egypt)
- Dr Zeng Bing (VP, China National Pharmaceutical Group Corp, SINOPHARM) – Invited
- Dr. Vishwa Mohan Katoch (Director, Indian Council of Medical Research)
- Mr Olivier Charmeil (Senior VP Asia/Pacific & Japan, Sanofi-aventis)
34
Workshop 2: How technology will help implementing innovative healthcare delivery?
Moderator: Dr Olivier Raynaud (Sr Director, Health Initiatives, World Economic Forum) - Provisional agreement
Introduction: TBD
- Ms. Maire Geoghegan-Quinn (European Commissioner, Research, Innovation and Science) – Provisional agreement
- Ms. Nathalie Kosciusko-Morizet (Secretary of State for Forward Planning and Development of the Digital Economy) – Provisional agreement
- M Neil de Crescenzo (Sr VP and General Manager, Oracle Health Sciences)
- Speaker from Cisco or Intel
35
Workshop 3: How to solve R&D’s challenge with Open Innovation?
Moderator: Dr André Choulika (President, France Biotech, France)
Introduction: TBD
- Pr. Lee Hood (President, Institute for Systems Biology, USA; Co-founder Amgen, Applied Biosystems, Rosetta, USA)
- Pr. Michel Goldman (Executive Director, Innovative Medicine Initiative)
- Dr Philippe Archinard (CEO, Transgene)
- Dr Vincent Schachter (VP, R&D, Total Gas and Power)
- M. Jacques Delort (VP, Prospective Strategic Initiatives, Sanofi-aventis)
36
Workshop 4: New Geography of R&D innovation in infectious and neglected diseases
Moderator: TBD
Introduction: Prof. Awa-Marie Coll Seck , Executive Director, Roll Back Malaria
- Dr Johan Van Hoof, (Global Therapeutic Area Head for Infectious Diseases & Vaccines, Head of the Global Development Organization, Pharmaceuticals Group, Johnson & Johnson)
- Dr. Robert Sebbag (VP, Access to Medicines, Sanofi-aventis)
- Dr. Thomas Lönngren (Executive Director, EMA)
- Pr. Françoise Barré-Sinoussi (Nobel Prize in Medicine 2008, Professor, Head of Unit of regulation of retroviral infections, Institut Pasteur, Paris, France)
- Dr. John A. Thomson (VP, Strategic R&D Networks, Vertex Pharmaceuticals)
- Speaker from Genzyme
37
38
Social Events
Gala Dinner (150 VIP) Sunday 27 March 2011
Seizing Nature’s opportunities would be good Mrs Julia Marton-Lefèvre (Director General, IUCN, Switzerland)
Welcoming Night (all participants) Sunday 27 March 2011
Innovation Dinner (150 VIP) Monday 28 March 2011
Biology inspires leaders and creators (to be confirmed)
Networking Night (all participants) Monday 28 March 2011
BioVision Award Tuesday 29 March 2011
39
CONTACT INFORMATION :
Fondation Scientifique de Lyon – BioVision - 210 avenue Jean Jaurès 69007 Lyon T : +33 (0)4 78 92 70 00 – F : +33 (0)4 78 92 70 15 - E-mail : [email protected]
www.biovision.org www.fslse.org
Avec le soutien de :
40